Emergence from Chapter 11 cases by RVL Subsidiaries indicate...
Emergence from Chapter 11 cases by RVL Subsidiaries indicates a stronger financial footing. However, the expected cancellation of RVL Pharmaceuticals plc's public equity in 2024 is not promising for current shareholders as they're left unrecovered.
Press Release: RVL Completes Financial Restructuring
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment